Kingdom Capital

AstrumU, Inc. operates a technology-driven platform that connects employers with recent graduates by quantifying the return on educational investment. Founded in 2017 and based in Kirkland, Washington, with an additional office in Kansas City, the company aims to enhance industry engagement and promote economic mobility. The AstrumU platform utilizes artificial intelligence to analyze data from students, educational institutions, and employers, providing predictive insights that help forecast the value of educational experiences in the labor market. This approach enables institutions and lifelong learners to make informed decisions about enrollment and career development based on verifiable skills and outcomes, fostering a more transparent and efficient marketplace for talent.

IntEngine, operating under Tanjing Technology, specializes in developing software algorithms and chip hardware technology aimed at enhancing efficiency in everyday life. The company focuses on deep learning and machine learning algorithms, providing tailored solutions for various Internet of Things (IoT) terminal devices. In addition to offering advanced digitalization solutions for industrial users, IntEngine develops end-side AI chips that improve the functionality and security of terminal equipment, including upgrades to security monitoring systems. Through its innovative approach, the company supports the growing demand for intelligent and efficient technology in diverse applications.

Canopy Biosciences, founded in 2016 and headquartered in St. Louis, Missouri, is a biotechnology company specializing in research tools for genetic engineering, molecular biology, and personalized medicine. The company offers a comprehensive range of products and services designed to facilitate gene editing, gene expression analysis, and bioprocessing. One of its key technologies, TUNR, targets translation elongation by inserting polyA tracks into specific coding regions of the genome, effectively reducing mRNA levels and suppressing protein expression. This innovative approach supports biomedical researchers at universities, research institutions, and within the biotechnology and pharmaceutical sectors, accelerating scientific discovery and enhancing the field of genetic engineering. Canopy Biosciences operates as a subsidiary of Bruker Corporation.